Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate 00406-8005-03
- Manufacturer
- Specgx Llc
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- December 13, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA207000
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
| Naloxone Hydrochloride Dihydrate | .5 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Selected Package
00406-8005-03Selected30 TABLET in 1 BOTTLE, PLASTIC (0406-8005-03)
External Resources